نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

biomed limited - adrenaline acid tartrate 0.18%{relative}; lidocaine hydrochloride monohydrate 4%{relative}; tetracaine hydrochloride 0.5%{relative} - topical solution - active: adrenaline acid tartrate 0.18%{relative} lidocaine hydrochloride monohydrate 4%{relative} tetracaine hydrochloride 0.5%{relative} excipient: sodium metabisulfite water for injection - topicaine is intended for use in adults and children older than 1 year, as a topical anaesthetic pain management when repairing wounds, particularly facial or scalp wounds.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide; sodium metabisulfite - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - adrenaline acid tartrate; prilocaine hydrochloride; adrenaline -

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - bupivacaine hydrochloride; lignocaine as lignocaine hydrochloride; adrenaline-l-acid tartrate-d; cetrimide - topical cream, ointment, paste, gel, lotion - bupivacaine hydrochloride anaesthetic active 4.2 g/l; lignocaine as lignocaine hydrochloride anaesthetic active 40.6 g/l; adrenaline-l-acid tartrate-d hormone active 24.8 mg/l; cetrimide ammonium-quaternary active 5.0 g/l - anaesthetics/analgesics - lamb with mulesing wound - post surgical pain

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - noradrenaline acid tartrate - 0.1 mg/ml

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.54 mg (equivalent: bupivacaine hydrochloride, qty 100 mg); adrenaline (epinephrine) acid tartrate, quantity: 182 microgram (equivalent: adrenaline (epinephrine), qty 100 microgram) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium chloride; water for injections - bupivacaine 0.5% with adrenaline 1:200,000 phebra is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows:,surgical anaesthesia ? epidural block for surgery ? field block (minor and major nerve blocks and infiltration) analgesia ? intermittent bolus epidural administration for analgesia in postoperative pain or labour pain ? field block (minor nerve block and infiltration)

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1 mg/ml;   - solution for injection - 1 mg/ml - active: adrenaline 1 mg/ml   excipient: sodium chloride sodium metabisulfite tartaric acid water for injection - latest regulatory activity